NCT01858740 · OUTCOME

Time to ANC of > 500/uL

Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in Children · Source last updated 2024-03-12

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: MEDIAN
Unit: Days
Interval / dispersion: Inter-Quartile Range
Time frame: Up to 5 years

What was measured

Time (in days) to ANC of \> 500/uL, counted as the first of three consecutive days post-transplant

Groups in this outcome

Overall Study Participants

All participants in single arm study received CD45RA+ T cell depletion PBSC transplant and IV Methotrexate and tacrolimus for GVHD prophylaxis

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Overall Study Participants	20

Reported measurements

Source class 1

Values in Days · Interval/dispersion: Inter-Quartile Range
Group	Value	Spread	Lower	Upper	Comment
Overall Study Participants	20.5	Not reported	19	24	Not reported

Complete source fields

classes

categories
measurements
group Id
OG000
lower Limit
19
upper Limit
24
value
20.5

denoms

counts
group Id
OG000
value
20
units
Participants

description

Time (in days) to ANC of \> 500/uL, counted as the first of three consecutive days post-transplant

dispersion Type

Inter-Quartile Range

groups

description
All participants in single arm study received CD45RA+ T cell depletion PBSC transplant and IV Methotrexate and tacrolimus for GVHD prophylaxis
id
OG000
title
Overall Study Participants

param Type

MEDIAN

reporting Status

POSTED

time Frame

Up to 5 years

title

Time to ANC of > 500/uL

type

SECONDARY

unit Of Measure

Days

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice